AssayIndex
CPC cross-section

CPC by compound

CPC records split by compound, with the index-wide comparison for the same compound beside each one. 27 compounds, 227 records. Cells below n=3 print their raw values instead of a median.

27 compounds227 records
CompoundClassReportsCPC median %Index median %Δ (pp)SpecPass %
TirzepatideIncretin2297.7198.55-0.8497.064
IpamorelinGrowth-hormone2098.5099.47-0.9799.030
GHRP-6Growth-hormone1899.8099.54+0.2699.0100
TB-500Tissue-repair1598.6499.53-0.8998.560
BPC-157Tissue-repair1498.7199.16-0.4598.0100
SemaxNeuroactive1498.4999.46-0.9798.550
GHK-CuTissue-repair1198.2598.56-0.3197.0100
KPVTissue-repair1198.3199.64-1.3399.09
LiraglutideIncretin897.2799.00-1.7297.525
RetatrutideIncretin897.0098.37-1.3796.5100
IGF-1 LR3Growth-hormone898.1698.28-0.1395.0100
SemaglutideIncretin898.4498.89-0.4597.0100
Kisspeptin-10Melanocortin-receptor898.6699.28-0.6298.588
L-Glutathione (reduced)Short7 n=798.3699.33-0.9798.529
MK-677 (Ibutamoren mesylate)Non-peptide7 n=798.7599.49-0.7498.5100
SelankNeuroactive7 n=798.9599.59-0.6499.043
ThymalinShort7 n=7n<399.0
N-Acetyl Semax AmideNeuroactive6 n=698.9999.35-0.3698.5100
CJC-1295 (no DAC)Growth-hormone5 n=597.8299.09-1.2798.00
HexarelinGrowth-hormone4 n=498.5399.59-1.0599.00
PT-141 (Bremelanotide)Melanocortin-receptor4 n=497.7799.38-1.6198.50
L-CarnosineShort3 n=398.9599.58-0.6399.033
GonadorelinHypothalamic3 n=398.8499.12-0.2898.5100
PemvidutideIncretin3 n=398.1098.25-0.1696.0100
AdipotideMetabolic3 n=397.4898.58-1.0996.0100
SS-31 (Elamipretide)Metabolic2 n=2n<399.5398.5100
Thymosin α1Tissue-repair1 n=1n<399.4097.5100
96.296.997.698.298.999.5100.2TirzepatideTirzepatide: Q1 96.80, median 97.71, Q3 98.44, n=22n=22IpamorelinIpamorelin: Q1 98.11, median 98.50, Q3 99.09, n=20n=20GHRP-6GHRP-6: Q1 99.61, median 99.80, Q3 99.93, n=18n=18TB-500TB-500: Q1 98.45, median 98.64, Q3 98.91, n=15outlier 99.76n=15BPC-157BPC-157: Q1 98.47, median 98.71, Q3 99.22, n=14n=14SemaxSemax: Q1 98.28, median 98.49, Q3 98.59, n=14outlier 97.54n=14GHK-CuGHK-Cu: Q1 98.14, median 98.25, Q3 98.56, n=11outlier 99.50n=11KPVKPV: Q1 98.16, median 98.31, Q3 98.59, n=11outlier 99.25n=11LiraglutideLiraglutide: Q1 97.12, median 97.27, Q3 97.40, n=8outlier 97.98n=8RetatrutideRetatrutide: Q1 96.61, median 97.00, Q3 97.06, n=8n=8IGF-1 LR3IGF-1 LR3: Q1 97.75, median 98.16, Q3 98.70, n=8n=8SemaglutideSemaglutide: Q1 97.94, median 98.44, Q3 98.60, n=8n=8Kisspeptin-10Kisspeptin-10: Q1 98.59, median 98.66, Q3 98.89, n=8outlier 99.53n=8L-Glutathione (reduce…L-Glutathione (reduce…: Q1 98.28, median 98.36, Q3 98.43, n=7outlier 98.72n=7 Purity (% area)
Figure. Distribution per compound where n ≥ 4. Rows are ordered by coverage, not by result.

Which of these lines CPC actually stocks

Coverage here reflects what has been submitted to the index, not what is on the catalogue. Chinese Peptide Company Co., Ltd. lists considerably more than the 27 compounds above. Of those 27, 15 have been seen arriving from a domestic warehouse rather than as a cross-border consignment — that is the whole of what the index can say about which lines are held in regional stock, and it is a record of what was submitted, not a stock position. The catalogue and the current stock position are on the supplier's own site.

Browse the CPC catalogue at chinesepeptidecompany.net →